United States · Venture startup

Who invested in Veramorph

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2025, from 1 source

Latest round
VentureOct 2025
Investors
3
See who backed them

The rounds

  1. Oct 2025

Founders and team

From the SEC filings it signed: 1 on the team.

  • Paul D. GodfrinExecutive Officer, Directori

Everyone who backed them

MassVenturesVC firm1round
National Cancer Institute (NCI)Investment firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Veramorph as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

CAV Angel NetworkAngel networkPer its own site

Quick answers about Veramorph

Who invested in Veramorph?

Veramorph's investors include National Science Foundation, MassVentures and National Cancer Institute (NCI).

How much has Veramorph raised?

Veramorph has raised 1 round since 2025, none with a disclosed amount.

When did Veramorph last raise?

Veramorph's most recent round was a Venture in Oct 2025.

Who backed Veramorph first?

Veramorph's first round on record, in Oct 2025, was backed by National Science Foundation, MassVentures and National Cancer Institute (NCI).

What stage is Veramorph at?

Veramorph's latest named round is a Venture, in Oct 2025.

Where is Veramorph based?

Veramorph is based in the United States.

Companies like Veramorph

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.